Zatz R - Search Results

1

FGF-23 as a predictor of renal outcome in diabetic nephropathy.

Titan SM, Zatz R, Graciolli FG, dos Reis LM, Barros RT, Jorgetti V, Moysés RM. Titan SM, et al. Among authors: zatz r. Clin J Am Soc Nephrol. 2011 Feb;6(2):241-7. doi: 10.2215/CJN.04250510. Epub 2010 Oct 21. Clin J Am Soc Nephrol. 2011. PMID: 20966122 Free PMC article. Clinical Trial.

2

Nephrology, dialysis and transplantation in Brazil.

Noronha IL, Schor N, Coelho SN, Jorgetti V, Romão Júnior JE, Zatz R, Burdmann EA. Noronha IL, et al. Among authors: zatz r. Nephrol Dial Transplant. 1997 Nov;12(11):2234-43. doi: 10.1093/ndt/12.11.2234. Nephrol Dial Transplant. 1997. PMID: 9394305 Review.

3

AT1 blockade during lactation as a model of chronic nephropathy: mechanisms of renal injury.

Machado FG, Poppi EP, Fanelli C, Malheiros DM, Zatz R, Fujihara CK. Machado FG, et al. Among authors: zatz r. Am J Physiol Renal Physiol. 2008 Jun;294(6):F1345-53. doi: 10.1152/ajprenal.00020.2008. Epub 2008 Apr 9. Am J Physiol Renal Physiol. 2008. PMID: 18400868 Free article.

4

Early brief treatment with losartan plus mycophenolate mofetil provides lasting renoprotection in a renal ablation model.

Fujihara CK, Vieira JM Jr, Sena CR, Ventura BH, Malheiros DM, Zatz R. Fujihara CK, et al. Among authors: zatz r. Am J Nephrol. 2010;32(2):95-102. doi: 10.1159/000315137. Epub 2010 Jun 15. Am J Nephrol. 2010. PMID: 20551627

5

ACEI and ARB combination therapy in patients with macroalbuminuric diabetic nephropathy and low socioeconomic level: a double-blind randomized clinical trial.

Titan SM, M Vieira J Jr, Dominguez WV, Barros RT, Zatz R. Titan SM, et al. Among authors: zatz r. Clin Nephrol. 2011 Oct;76(4):273-83. doi: 10.5414/cn107013. Clin Nephrol. 2011. PMID: 21955862 Clinical Trial.

6

Urinary MCP-1 and RBP: independent predictors of renal outcome in macroalbuminuric diabetic nephropathy.

Titan SM, Vieira JM Jr, Dominguez WV, Moreira SR, Pereira AB, Barros RT, Zatz R. Titan SM, et al. Among authors: zatz r. J Diabetes Complications. 2012 Nov-Dec;26(6):546-53. doi: 10.1016/j.jdiacomp.2012.06.006. Epub 2012 Sep 12. J Diabetes Complications. 2012. PMID: 22981148 Clinical Trial.

7

Furosemide Increases the Risk of Hyperparathyroidism in Chronic Kidney Disease.

Vasco RF, Moyses RM, Zatz R, Elias RM. Vasco RF, et al. Among authors: zatz r. Am J Nephrol. 2016;43(6):421-30. doi: 10.1159/000446449. Epub 2016 May 28. Am J Nephrol. 2016. PMID: 27231243 Free article.

8

Titan SM, Venturini G, Padilha K, Tavares G, Zatz R, Bensenor I, Lotufo PA, Rhee EP, Thadhani RI, Pereira AC. Titan SM, et al. Among authors: zatz r. Clin Chim Acta. 2019 Feb;489:242-248. doi: 10.1016/j.cca.2018.08.037. Epub 2018 Aug 25. Clin Chim Acta. 2019. PMID: 30153452

9

1,5-Anhydroglucitol predicts CKD progression in macroalbuminuric diabetic kidney disease: results from non-targeted metabolomics.

Tavares G, Venturini G, Padilha K, Zatz R, Pereira AC, Thadhani RI, Rhee EP, Titan SMO. Tavares G, et al. Among authors: zatz r. Metabolomics. 2018 Feb 27;14(4):39. doi: 10.1007/s11306-018-1337-9. Metabolomics. 2018. PMID: 30830377 Clinical Trial.

10

Design and methodology of the Aging Nephropathy Study (AGNES): a prospective cohort study of elderly patients with chronic kidney disease.

Coelho VA, Santos GG, Avesani CM, Bezerra CIL, Silva LCA, Lauar JC, Lindholm B, Stenvinkel P, Jacob-Filho W, Noronha IL, Zatz R, Moysés RMA, Elias RM. Coelho VA, et al. Among authors: zatz r. BMC Nephrol. 2020 Nov 7;21(1):461. doi: 10.1186/s12882-020-02116-w. BMC Nephrol. 2020. PMID: 33160321 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

118 results

Search Page